U.S. Food and Drug Administration, amended the emergency use authorizations (EUAs), of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations.
FDA, BA 5 vaccine
U.S. Food and Drug Administration, amended the emergency use authorizations (EUAs), of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations.